174 related articles for article (PubMed ID: 15794383)
1. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study.
Versijpt J; Debruyne JC; Van Laere KJ; De Vos F; Keppens J; Strijckmans K; Achten E; Slegers G; Dierckx RA; Korf J; De Reuck JL
Mult Scler; 2005 Apr; 11(2):127-34. PubMed ID: 15794383
[TBL] [Abstract][Full Text] [Related]
2. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
Giannetti P; Politis M; Su P; Turkheimer FE; Malik O; Keihaninejad S; Wu K; Waldman A; Reynolds R; Nicholas R; Piccini P
Brain; 2015 Jan; 138(Pt 1):110-9. PubMed ID: 25416179
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
[TBL] [Abstract][Full Text] [Related]
5. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
Debruyne JC; Versijpt J; Van Laere KJ; De Vos F; Keppens J; Strijckmans K; Achten E; Slegers G; Dierckx RA; Korf J; De Reuck JL
Eur J Neurol; 2003 May; 10(3):257-64. PubMed ID: 12752399
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
[TBL] [Abstract][Full Text] [Related]
7. Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.
Kaunzner UW; Kang Y; Monohan E; Kothari PJ; Nealon N; Perumal J; Vartanian T; Kuceyeski A; Vallabhajosula S; Mozley PD; Riley CS; Newman SM; Gauthier SA
Mult Scler Relat Disord; 2017 Jul; 15():27-33. PubMed ID: 28641769
[TBL] [Abstract][Full Text] [Related]
8. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
[TBL] [Abstract][Full Text] [Related]
9. Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET.
Kannan S; Saadani-Makki F; Muzik O; Chakraborty P; Mangner TJ; Janisse J; Romero R; Chugani DC
J Nucl Med; 2007 Jun; 48(6):946-54. PubMed ID: 17504871
[TBL] [Abstract][Full Text] [Related]
10. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.
Banati RB; Newcombe J; Gunn RN; Cagnin A; Turkheimer F; Heppner F; Price G; Wegner F; Giovannoni G; Miller DH; Perkin GD; Smith T; Hewson AK; Bydder G; Kreutzberg GW; Jones T; Cuzner ML; Myers R
Brain; 2000 Nov; 123 ( Pt 11)():2321-37. PubMed ID: 11050032
[TBL] [Abstract][Full Text] [Related]
11. Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients.
Debruyne JC; Van Laere KJ; Versijpt J; De Vos F; Eng JK; Strijckmans K; Santens P; Achten E; Slegers G; Korf J; Dierckx RA; De Reuck JL
Acta Neurol Belg; 2002 Sep; 102(3):127-35. PubMed ID: 12400251
[TBL] [Abstract][Full Text] [Related]
12. Regional but not global brain damage contributes to fatigue in multiple sclerosis.
Rocca MA; Parisi L; Pagani E; Copetti M; Rodegher M; Colombo B; Comi G; Falini A; Filippi M
Radiology; 2014 Nov; 273(2):511-20. PubMed ID: 24927473
[TBL] [Abstract][Full Text] [Related]
13. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
[TBL] [Abstract][Full Text] [Related]
14. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
15. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
Sanfilipo MP; Benedict RH; Sharma J; Weinstock-Guttman B; Bakshi R
Neuroimage; 2005 Jul; 26(4):1068-77. PubMed ID: 15961046
[TBL] [Abstract][Full Text] [Related]
16. 18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis.
Singhal T; OʼConnor K; Dubey S; Belanger AP; Hurwitz S; Chu R; Tauhid S; Kijewski MF; DiCarli MF; Weiner HL; Bakshi R
Clin Nucl Med; 2018 Sep; 43(9):e289-e295. PubMed ID: 30004939
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.
Kang Y; Schlyer D; Kaunzner UW; Kuceyeski A; Kothari PJ; Gauthier SA
PLoS One; 2018; 13(8):e0201289. PubMed ID: 30091993
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
Zhou F; Shiroishi M; Gong H; Zee CS
J Magn Reson Imaging; 2010 Apr; 31(4):789-95. PubMed ID: 20373421
[TBL] [Abstract][Full Text] [Related]
19. Natalizumab treatment reduces microglial activation in the white matter of the MS brain.
Sucksdorff M; Tuisku J; Matilainen M; Vuorimaa A; Smith S; Keitilä J; Rokka J; Parkkola R; Nylund M; Rinne J; Rissanen E; Airas L
Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e574. PubMed ID: 31355310
[TBL] [Abstract][Full Text] [Related]
20. Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study.
Giannetti P; Politis M; Su P; Turkheimer F; Malik O; Keihaninejad S; Wu K; Reynolds R; Nicholas R; Piccini P
Neurobiol Dis; 2014 May; 65():203-10. PubMed ID: 24508617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
